Skip to main content
 This program is no longer active, however there are other versions of this program in which you may be interested.

Psychopharmacology for Mental Health Professionals, 5/14/2024 7:00:00 AM CDT, Live Webinar More info »
Psychopharmacology for Mental Health Professionals, 7/14/2023 12:00:00 AM CDT, Digital Seminar More info »
Psychopharmacology for Mental Health Professionals, 7/14/2023 12:00:00 AM CDT, DVD More info »
Not Found
Live Webinar

Psychopharmacology for Mental Health Professionals


Speaker:
Alan S. Bloom, PhD
Duration:
Full Day
Format:
Audio and Video
Product Code:
LWC045905
Brochure Code:
IHW89026
Media Type:
Live Webinar - Also available: Digital Seminar | DVD | Live Webinar

Dates

Normal Price:      $249.99 - Now:  $49.99 - Exclusive offer when combined with this live training.
Other great resources - exclusive savings when you add now!

Description

Most clients with DSM-5® diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential.

This seminar will update and increase your knowledge of:

  • Neurobiological underpinnings of major DSM-5® diagnoses
  • Effects and side effects of drugs used to treat these diagnoses
  • Responsibilities of the non-prescribing therapist to clients taking psychiatric medication

Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this webcast is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5® disorders. You will leave this program with knowledge and confidence regarding effective and safe application of pharmacological drugs.

Credit

Planning Committee Disclosure - No relevant relationships

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.



* Credit Note - *

NOTE: Tuition includes one free CE Certificate. For the in-person event, after attendance has been verified, pre-registered attendees will need to log into their online account to complete the online evaluation (and, if applicable for your profession, the online post-test with 80% passing score). Instructional methods will include PowerPoint, didactic lecture, Q&A, and others. After completion of the evaluation (and post-test, if applicable), participants can download/print their certificate of completion. For those in partial attendance (arrived late or left early), a letter of attendance will be available in the attendee online account after completion of the evaluation and online post-test (if the test is required for your profession). An adjusted certificate of completion reflecting partial credit will be sent within 30 days (if your board allows).

Continuing Education Information: Credits listed below are for full attendance at the live, in-person event only. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact info@pesi.com or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.

For Planning Committee disclosures, please see statement above.  For speaker disclosures, please see the faculty biography.


Counselors - California Counselors

The California Board of Behavioral Sciences accepts CE programs that are approved by other approval agencies, including several that approve PESI and its programs.  A full list of approval agencies accepted by the BBS can be found at www.bbs.ca.gov/licensees/cont_ed.html under “Where to find CE Courses.”  This intermediate level level activity consists of 6.0 clock hours of continuing education instruction.


Counselors - Counselors

This activity consists of 6.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.


Social Workers - Social Workers - National ASWB ACE

PESI, Inc., #1062, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. PESI, Inc. maintains responsibility for this course. ACE provider approval period: January 27, 2023 - January 27, 2026. Social workers completing this course receive 6.25 Clinical continuing education credits.

 

Course Level: Intermediate Format: Synchronous distance.  Full attendance is required; no partial credits will be offered for partial attendance.

 

Canadian Social Workers: Canadian provinces may accept activities approved by the ASWB for ongoing professional development.


Social Workers - California Social Workers

The California Board of Behavioral Sciences accepts CE programs that are approved by other approval agencies, including several that approve PESI and its programs.  A full list of approval agencies accepted by the BBS can be found at www.bbs.ca.gov/licensees/cont_ed.html under “Where to find CE Courses.” This intermediate level activity consists of 6.0 clock hours of continuing education instruction.


Psychologists - California Psychologists

CE credit is available. This course consists of 6.0 continuing education credit hours for California Psychologists. The California Department of Consumer Affairs Board of Psychology recognizes and accepts for continuing education credit courses that are specifically applicable and pertinent to the practice of psychology and by entities approved by the ACCME (Accreditation Council for Continuing Medical Education). This live activity is certified for a maximum of 6.0 AMA PRA Category 1 Credits™ by PESI as an accredited ACCME provider authorized to award credit by the AMA. PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Psychologists - Psychologists & Physicians

Physicians: PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. This activity was originally recorded on . It was last reviewed on  and is valid until .  Physicians should only claim credit commensurate with the extent of their participation in the activity. You are required to successfully complete and submit a post-test prior to receiving a certificate of completion.


Psychologists: The following state psychologist boards recognize activities sponsored by PESI, Inc. as an approved ACCME provider: Alaska, Arkansas, California, Colorado, Georgia, Illinois, Indiana, Kentucky, Maine, Maryland, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, Oklahoma, Pennsylvania, South Carolina and Wisconsin. This activity consists of 6.0 clock hours of continuing education instruction. You are required to successfully complete and submit a post-test prior to receiving a certificate of completion.


Marriage & Family Therapists - Marriage & Family Therapists

This activity consists of 380 minutes of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the activity advertisement, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements. 


Marriage & Family Therapists - California Marriage & Family Therapists

The California Board of Behavioral Sciences accepts CE programs that are approved by other approval agencies, including several that approve PESI and its programs.  A full list of approval agencies accepted by the BBS can be found at www.bbs.ca.gov/licensees/cont_ed.html under “Where to find CE Courses.”  This intermediate level activity consists of 6.0 clock hours of continuing education instruction.


Addiction Counselors - NAADAC

NAADAC

This course has been approved by PESI, Inc., as a NAADAC Approved Education Provider, for 6.0 CE in the Counseling Services skill group. NAADAC Provider #77553. PESI, Inc. is responsible for all aspects of their programming. Full attendance is required; no partial credit will be awarded for partial attendance. 


California Alcoholism & Drug Abuse Counselors (CADTP)

PESI, Inc. is an approved provider by the CADTP, Provider #: 201. This Category C activity meets the qualifications for 6.0 CEUs (continuing education hours).


California Alcoholism & Drug Abuse Counselors (CCAPP-EI)

PESI, Inc. is an approved provider by the CCAPP-EI, Provider #: 0S-03-036-1023. This activity meets the qualifications for 6.0 CEHs (continuing education hours).


California Licensed Educational Psychologists

The California Board of Behavioral Sciences accepts CE programs that are approved by other approval agencies, including several that approve PESI and its programs.  A full list of approval agencies accepted by the BBS can be found at www.bbs.ca.gov/licensees/cont_ed.html under “Where to find CE Courses.”  This intermediate level activity consists of 6.0 clock hours of continuing education instruction.


Pharmacology Nurse Practitioners

This program offers 180 instructional minutes of pharmacology content which is designed to qualify for 3.0 contact hours toward your pharmacology requirement to receive credit. It is your responsibility to submit your certificate of successful completion and a copy of the seminar brochure to your licensing board. 


Nurses, Nurse Practitioners, and Clinical Nurse Specialists - ANCC

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses in full attendance will earn 6.25 contact hours. Partial contact hours will be awarded for partial attendance.


California Nurses

PESI, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number 17118 for 6.0 contact hours. Full attendance is required. No partial contact hours will be issued for partial attendance. 


Other Professions

This activity qualifies for 380 continuing education minutes as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements. 



Handouts/Brochure

Speaker

Alan S. Bloom, PhD's Profile

Alan S. Bloom, PhD Related seminars and products


Alan S. Bloom, PhD, is Professor Emeritus of Pharmacology and Toxicology at the Medical College of Wisconsin where he taught psychopharmacology to medical students and neuroscience graduate students. He earned a joint PhD in psychology and pharmacology and consults regularly with psychiatrists and attorneys in drug abuse and other pharmacology related cases.  
 
Dr. Bloom has conducted extensive research on the impact of drugs of abuse (marijuana, cocaine, etc.) on the brain through use of functional magnetic resonance imaging (fMRI). His studies have been funded by the NIH and other national organizations and reported in an extensive number of publications and presentations. Dr. Bloom has served on the NIDA Center grant review panel and is an appointed member of the Controlled Substance Board of the State of Wisconsin.  
 
Dr. Bloom is a strong and experienced presenter providing lively, information-packed seminars. He encourages the active learning of participants through application of the material in case studies and problem-based learning. In 1997 he was elected to membership in the Medical College of Wisconsin Society of Teaching Scholars.  

 

Speaker Disclosures:
Financial: Dr. Alan Bloom receives a speaking honorarium and recording royalties from PESI, Inc. Dr. Bloom has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Alan Bloom is the Vice Chair of the State of Wisconsin Controlled Substances Board.


Alternate Dates

Psychopharmacology for Mental Health Professionals
Tue, May 14, 2024 - 07:00am to 03:00pm CDT - Product Code LWC045905

Objectives

  1. Communicate the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy.
  2. Evaluate the role of mental health professionals who treat clients receiving both psychotherapeutic medications and psychotherapy.
  3. Analyze the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs.
  4. Analyze the effects and side effects of various psychotropic medications, including antipsychotics, antidepressants, benzodiazepines and anticonvulsants.
  5. Determine the abuse liability of drugs used in the treatment of anxiety, insomnia, pain and ADHD.
  6. Implement methods for prevention and early identification of prescription drug abuse among clients.

Outline

Psychopharmacological Foundations
Core Pharmacological Principles
  • Brain structures & circuits involved in:
    • Emotional regulation
    • Executive function & inhibitory control
    • Reward & pleasure
    • Learning & memory
  • Receptors and neurotransmitters important in the actions of psychopharmacological agents
    • Biogenic amines
    • Excitatory & inhibitory neurotransmitters
    • Endorphins & endocannabinoids
Your role in combined psychological & pharmacological treatments
  • Collaboration & communication with prescribing professionals
  • Managing the combined treatments
    • Referrals for medication
    • Client psycho-education
    • Monitoring drug effects & side effects
    • Promoting adherence to combined treatments
Drugs Used in the Treatment of DSM-5® Mental Disorders

Depressive Disorders

  • Neurobiology of depression
  • Drugs used to treat depressive disorders
    • Selective Serotonin Reuptake inhibitors (SSRIs)
      • Effects, side effects and cautions
      • Suicide risk & discontinuation syndrome
      • Serotonin syndrome
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    • Effects, side effects, and cautions
  • Atypical antidepressant agents
    • Effects, side effects, and cautions
  • Tricyclic antidepressants (TCAs)
    • Effects, side effects, and cautions
    • Why were newer drugs needed?
  • MAO inhibitors
    • Effects, side effects, and cautions
  • Choosing an antidepressant
  • What if first-line antidepressants do not work?
    • Augmentation with antipsychotics
  • What about herbs like St. John’s Wort?
Schizophrenia Spectrum Disorders
  • Biological theories of schizophrenia
  • ”Typical” & “atypical” antipsychotic drugs
    • Effects, side effects & cautions – similarities & differences
  • Latest evidence-based comparisons
  • Drugs for treatment-resistant schizophrenia
  • Other uses of antipsychotic drugs
Bipolar Disorders
  • Biological theories for bipolar disorders
  • Drugs used to treat bipolar disorders
    • A prototype agent – lithium
      • Effects, side effects & cautions
    • Anticonvulsants
      • Effects, side effects & cautions
    • Antipsychotics – approved agents
    • Combination drug therapy
Anxiety, Obsessive-Compulsive & Sleep-Wake Disorders
  • The neurobiology of anxiety-related disorders
  • The structure of sleep
  • Drugs used in the treatment of anxiety & insomnia
    • Benzodiazepines & Benzodiazepine-like drugs
    • Misuse of these drugs in treatment
    • SSRI’s & other drugs used to treat anxiety
Attention-Deficit/Hyperactivity Disorder & Neurocognitive Disorders (Dementia)
  • ADHD
    • Psycho-stimulants
      • Effects, side effects & cautions
    • Alpha-Adrenergic Agonists
  • Major neurocognitive disorders
    • Drugs used in the treatment of cognitive impairment
    • Future treatments
Prescription Drug Abuse
  • Mental disorders & risk of comorbid prescription drug abuse
  • Classes of drugs that are frequently abused
    • Stimulants
    • Sedative-hypnotics
    • Opiates
  • Strategies for the prevention & early identification of prescription drug abuse
Limitations of the Research and Potential Risks

Target Audience

  • Counselors
  • Psychotherapists
  • Psychologists
  • Social Workers
  • Nurse Practitioners
  • Case Managers
  • Marriage & Family Therapists
  • Addiction Counselors
  • Nurses
  • Physicians
  • Clinical Nurse Specialists
  • Pharmacists
  • School Psychologists
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Other Mental Health Professionals

Reviews

5
4
3
2
1

Overall:      4.3

Total Reviews: 12

Comments

Sarah W

"great program. SO informational!"

Jacqueline T

"Super informative course!"

ELISE K

"the whole experience was excellent"

LARA W

"Both the presenter and the quality of the information were fantastic."

Leslie S

"Great seminar, thank you!"

Natalie B

"Excellent course and presentation."

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

https://cdn.pesi23.com/images/android.png     https://cdn.pesi23.com/images/iphone.png

Please wait ...

Back to Top